AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Neulasta (Amgen) (neulasta.com)
This is a substance-heavy pharmaceutical site where the BS score is suppressed by strict regulatory compliance and clinical data. The primary indicators of bullshit are technical (missing schema and H1 tags) and the presence of unverified ‘trust theatre’ metrics like unlinked patient satisfaction percentages.
Implement comprehensive Product and HealthcareOrganization schema to programmatically anchor the brand’s authority and product specifications. Fix the technical implementation by adding descriptive H1 tags to the homepage and infection-related pages. Replace internal brochure links with direct outbound citations to the original peer-reviewed studies to move beyond trust theatre. Consolidate repetitive value proposition blocks to improve the unique information density of each sub-page.
The site maintains a high substance-to-fluff ratio, providing granular technical details such as 6 mg/0.6 mL dosages and specific active ingredients like pegfilgrastim. Substance is found in the body text detailing a key study of 928 patients and clinical results showing a 94 percent reduction in FN. However, the density is penalized for heavy concept repetition, specifically the Important Safety Information and the 5 dollar out-of-pocket cost claim, which appear verbatim across all four crawled pages.
Black hole nodes and terminal leaf pages distort your hierarchy and weaken retrieval. Run a full Internal Linking Architecture analysis to expose the structural gaps hidden inside your graph.
Signal-substance alignment is near-perfect; the homepage hero signal of helping prevent FN and reducing hospitalization is rigorously supported by the technical sub-pages detailing chemotherapy risks and clinical trial outcomes. There is no messaging drift, as the positioning remains consistent for both patients and healthcare professionals throughout the journey. The heading hierarchy across sub-pages directly supports the homepage’s value proposition of home-based infection management.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The site exhibits trust theatre through a review_count of 2 to 3 across pages with a trust_theatre_flag set to true, while the proof_links_count remains 0. While patient satisfaction claims like 95 percent of patients would choose Onpro again are featured, they lack direct external validation links in the analyzed text. Performance claims regarding hospitalizations are bold but rely on internal citations rather than outbound links to third-party medical journals.
Proof density is high, with the site moving beyond vague assertions to provide specific percentages: 94 percent reduction in FN incidence and 93 percent reduction in FN-related hospitalizations. Verifiable evidence includes a detailed breakdown of serious side effects (e.g., Spleen Rupture, ARDS) and a glossary of cancer terms. Unsubstantiated claims are minimal, limited mostly to patient preference surveys lacking external documentation.
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site follows a standard pharmaceutical commodity template, including sections for Patient Resources and Important Safety Information. While it uses industry-standard jargon like biosimilar and FDA approved, these are used as specific technical deliverables rather than generic marketing fluff. The unique value proposition of the Onpro on-body injector differentiates the brand from generic pegfilgrastim competitors.
A notable technical authority gap exists because the schema_json is null for all analyzed pages, failing to provide structured data for the Organization or Product despite claims of serving ~1 million patients. Furthermore, the homepage and the Infection Caused by Chemo page are missing H1 tags, representing a disconnect between the brand’s stated authority and its technical SEO implementation. No specific Person schema is provided for medical directors or expert contributors.
The marketing tone is restrained by legal compliance, ensuring that performance claims like reduces your risk of being hospitalized are immediately paired with safety warnings and clinical context. The site demonstrates what it claims by providing actual instructions for use and mechanism of action videos. There is no disconnect between the ‘breakthrough’ nature of the device and the provided instructional substance.
Medical Devices, Pharma & Biotech BS: Neulasta (Amgen) (neulasta.com)
The site is an exact match for the Pharma and Biotech category, utilizing highly specialized medical terminology such as febrile neutropenia (FN), granulocyte colony-stimulating factor (G-CSF), and myelosuppressive chemotherapy. The content structure is dictated by regulatory requirements, focusing on the mechanism of action and therapeutic area of pegfilgrastim.
Your site's meaning is determined by its graph, not its menus. Review the Internal Linking Architecture Framework to see how AI interprets nodes, edges, and authority flow inside your domain.
“The score of 26 represents low BS. The score was driven up by the trust_and_proof pillar (10 points) due to the presence of unverified review counts and the identity_and_authority pillar (7 points) due to the complete lack of structured data. Information density is high, but the repetitive nature of the content prevented a perfect score in that category.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Neulasta (Amgen) to view the most current version of their content and see directly what the company offers.